Background: Vaccinations for animals are crucial for food production, animal welfare, public health, and animal health. They are an affordable way to stop animal sickness, increase food production efficiency, and lessen or stop the spread of zoonotic diseases to humans. Animal vaccines that are both safe and efficacious are vital to modern culture. The vaccine should induce a strong, protective and prolonged immune response against the antigenic factor. In order to achieve these goals, novel vaccination techniques and an efficient adjuvant are required to render the vaccine immunogenically protective and trigger a strong immune response. Aim: Our study aims to promote and enhance the immunogenicity against RVF virus disease through lyophilized inactivated RVF vaccine through induction of early cellular, high and prolonged humeral immunity in vaccinated animals using cabopol as stabilizer and Saponin or normal saline as a diluent at time of vaccination. Moreover, manufacturing of these vaccines is easy to be done. Results: The gained results revealed that RVF freeze-dried vaccine with Carbopol that reconstituted using Saponin elicited better immune response than that reconstituted using normal saline (NaCl). The cell mediated immune response as represented by lymphocyte blastogenesis and phagocytic activity were markedly increased with high levels when we used Saponin as a diluent than that in group vaccinated with vaccine diluted with NaCl, on the other side the humeral immune response in group vaccinated using the Saponin as diluent is more detected and stayed within the protective level till the end of 11th month post vaccination (1.5 TCID50) while the immune response induced after using normal saline as a diluent stayed within the protective level till the end of 10th month post vaccination (1.8 TCID50). Conclusion: The use of Saponin as a diluent for reconstitution of the freeze dried RVF vaccine is preferable than the use of normal saline enhancing both sheep cellular and humeral immune response.
References
[1]
WHO (2020) Rift Valley Fever-Mauritania, 20 October 2020.
[2]
Nguku, P.M., Sharif, S.K., Mutonga, D., Amwayi, S., Omolo, J., Mohammed, O., Farnon, E.C., Gould, L.H., Lederman, E., Rao, C., Sang, R., Schnabel, D., Feikin, D.R., Hightower, A., Njenga, M.K. and Breiman, R.F. (2006) An Investigation of a Major Outbreak of Rift Valley Fever in Kenya. The American Journal of Tropical Medicine and Hygiene, 83, 5-13. https://doi.org/10.4269/ajtmh.2010.09-0288
[3]
CDC (Centers for Disease Control and Prevention) (2023) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP), Viral Special Pathogens Branch (VSPB), June 8, 2023.
Abdel Ghaffar, S., Mohsen, A., Ayoub, N., El Nimr, M. and Fathia, M. (1979) Rift Valley Fever in Egypt III. Diagnosis and Vaccination. Proceedings of the 14th Arab Veterinary Congress, Cairo, 24-29 March 1979, 1-11.
[6]
Faburay. B., Labeaud, A.D., Mcvey, D.S. and William, C.W. (2017) The Involving Transmission Pattern of Rift Valley Fever in the Arabian Peninsula. Academy of Sciences, 969, 201-204.
[7]
Hubbard, K.A., et al. (1991) The Ability of a Mutagenized Virus Variant to Protect Young Lambs from Rift Valley Fever. American Journal of Veterinary Research, 52, 50-55. https://doi.org/10.2460/ajvr.1991.52.01.50
Bomford, R. (1998) Will Adjuvants Be Needed for Vaccines of the Future? In: Brown, F. and Haaheim, L.R., Eds., Modulation of the Immune Response to Vaccine Antigens, Vol. 92, Development in Biological Standardization, Basel, 13-17.
[10]
Saad, S., Shalakamy, E., Kalad, M.A. and El-Kabbany, M.M.A. (2003) Preparation of Inactivated Freeze Dried RVF Vaccine. Egyptian Journal of Agricultural Research, 81, 1239-1247. https://doi.org/10.21608/ejar.2003.282813
[11]
Wassel, M.S., Taha, M.M., El-Ebiary, E.A., Mohamed, Z.E. and Mohsen, A.Y.A. (1992) Preliminary Studies on Freeze Dried Inactivated RVF Vaccine in Egypt. Assiut Veterinary Medical Journal, 26, 76-82. https://doi.org/10.21608/avmj.1992.187341
[12]
Aly, N.E., Atwa, M.H., Abbas, A.M., Abulmagd, D.M., Salem, Z.T. and Sayed, T.A. (2023) Immunogenicity of a Freeze-Dried Combined Vaccine against Rift Valley Fever and Bovine Ephemeral Fever in Cattle. Open Veterinary Journal, 13, 826-833. https://doi.org/10.5455/OVJ.2023.v13.i7.3
[13]
Atwa, M.H., et al. (2020) Efficacy of Freeze Dried Inactivated Rift Valley Fever Vaccine. Journal of Applied Veterinary Sciences, 5, 33-39. https://doi.org/10.21608/javs.2020.85571
[14]
Islam, M.T., Rodríguez-Hornedo, N., Ciotti, S. and Ackermann, C. (2004) Rheological Characterization of Topical Carbomer Gels Neutralized to Different pH. Pharmaceutical Research, 21, 1192-1199. https://doi.org/10.1023/B:PHAM.0000033006.11619.07
[15]
Zhang, Y., Ng, W., Hu, J., Mussa, S.S., Ge, Y. and Xu, H. (2018) Formulation and in Vitro Stability Evaluation of Ethosomal Carbomer Hydrogel for Transdermal Vaccine Delivery. Colloids and Surfaces B: Biointerfaces, 163, 184-191. https://doi.org/10.1016/j.colsurfb.2017.12.031
[16]
Ahuja, A., Khar, R.K. and Ali, J. (1997) Mucoadhesive Drug Delivery Systems. Drug Development and Industrial Pharmacy, 23, 489-505. https://doi.org/10.3109/03639049709148498
[17]
Gartlan, K.H., Krashias, G., Wegmann, F., Hillson, W.R., Scherer, E.M., Greenberg, P.D., Eisenbarth, S.C., Moghaddam, A.E. and Sattentau, Q.J. (2016) Sterile Inflammation Induced by Carbopol Elicits Robust Adaptive Immune Responses in the Absence of Pathogen-Associated Molecular Patterns. Vaccine, 34, 2188-2196. https://doi.org/10.1016/j.vaccine.2016.03.025
[18]
Mair, K.H., Koinig, H., Gerner, W., Hone, A., Bretthauer, J., Kroll, J.J., Roof, M.B., Saalmuller, A., Stadler, K. and Libanova, R. (2015) Carbopol Improves the Early Cellular Immune Responses Induced by the Modified-Life Vaccine Ingelvac PRRS® MLV. Veterinary Microbiology, 176, 352-357. https://www.researchgate.net/publication/272199497 https://doi.org/10.1016/j.vetmic.2015.02.001
[19]
Oda, K., Matsuda, H., Murakami, T., Katayama, S., Ohgitani, T. and Yoshikawa, M. (2000) Adjuvant and Hemolytic Activities of 47 Saponins Derived from Medicinal and Food Plants. Biological Chemistry, 381, 67-74. https://doi.org/10.1515/BC.2000.009
[20]
Jie, Y.H., Cammisuli, S. and Baggliolini, M. (1984) Immunomodulatory Effects of Panax Ginseng C.A. Meyer in the Mouse. Agents Actions, 15, 386-391. https://doi.org/10.1007/BF01972376
[21]
Kensil, C.R. (1996) Saponins as Vaccine Adjuvants. Critical Reviews™ in Therapeutic Drug Carrier Systems, 13, 1-55.
[22]
Farag, M.A., El-Kilany, S. and Abdel El-Rahman, A.O. (2006) The Impact of Live Animal Importation on the Epizootiology of Foot and Mouth Disease in Egypt. Proceedings of the 8th Scientific Veterinary Medicine Zagreb Conference, Hurghada, August 31 2006-September 3, 2006.
[23]
Bahnemann, H.G. (1975) Binary Ethyleneimine as Inactivant for Foot and Mouth Disease Virus and Its Application for Vaccine Production. Archives of Virology, 47, 47-56. https://doi.org/10.1007/BF01315592
[24]
Mellencamp, M.W. (2004) Chemically Inactivated EHV-1 Kya Virus; and an Adjuvant Which Includes Cross Link Edolefinically Unsaturated Carboxylic Acid Polymer. Patents, Publication Number US 6803041 B2.
[25]
United States Pharmacopeia (2022) NF Monographs, Carbomer 934 p. USP-NF. Rockville, 1900-1911.
[26]
Aly, N.E., Atwa, M.H., Abbas, A.M., et al. (2023) Immunogenicity of a Freeze-Dried Combined Vaccine against Rift Valley Fever and Bovine Ephemeral Fever in Cattle. Open Veterinary Journal, 13, 826-833. https://doi.org/10.5455/OVJ.2023.v13.i7.3
[27]
Amoros, M., Fauconnier, B. and Girre, R.L. (1987) In Vitro Antiviral Activity of a Saponin from Anagallisarvensis, Primulaceae, against Herpes Simplex Virus and Poliovirus. Antiviral Research, 8, 13-25. https://doi.org/10.1016/0166-3542(87)90084-2
[28]
Rossiter, P.B., Jesset, D.M. and Taylor, W.P. (1985) Microneutralization System for Use with Different Strains of Pest Des Petit Ruminant’s Virus and Rinderpest Virus. Tropical Animal Health and Production, 17, 75-81. https://doi.org/10.1007/BF02360775
[29]
Reed, L.J. and Muench, H. (1938) A Simple Method for Estimating 50 Percent Endpoint. American Journal of Epidemiology, 27, 493-497. https://doi.org/10.1093/oxfordjournals.aje.a118408
[30]
OIE (2018) RVF (Infection with Rift Valley Fever Virus) Chapter 3.1.18. 613-633. https://www.woah.org/app/uploads/2021/03/3-01-18-rvf-1.pdf
[31]
Randal, R., Binn, L.N. and Harrison, V.R. (1964) Immunization against RVFV. Studies on the Immunogenicity of Lyophilized Formalin Inactivated Vaccine. The Journal of Immunology, 93, 293-299. https://doi.org/10.4049/jimmunol.93.2.293
[32]
Mayr, A., Thein, P. and Scheid, N. (1978) Immunization Experiments with Inactivated EHV-1. Proceedings of the 4th International Conference on Equine Infectious Diseases, Lyon, 57-67.
[33]
Nehal, S.S. (2006) Preliminary Trials for the Production of Equine Viral Abortion Inactivated Vaccine. Ph.D. Thesis, Virology Benha University, Qualyobia.
[34]
Code of Federal Regulation (2005) Animal and Animal Products 9, Published by the Office of Federal Register National Archives and Administration. Veterinary Microbiology, 16, 1-107.
[35]
OIE (2018) Tests for Sterility and Freedom from Contamination of Biological Materials Intended for Veterinary Use. Chapter 1.1.9. 109-112. https://www.woah.org/fileadmin/Home/eng/Health_standards/tahm/1.01.09_TESTS_FOR_STERILITY.pdf
[36]
Scudiero, D.A., Shoemaker, R.H., Paull, K.D., Monks, A., Tierney, S., Nofziger, T.H., Currens, M.J., Seniff, D. and Boyd, M.R. (1988) Evaluation of Soluble Tetrazolium/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumer Cell Lines. Cancer Research, 48, 4827-4833.
[37]
Harmon, B.G. and Glisson, J.R. (1989) In Vitro Microbial Activity of Avian Peritoneal Macrophages. Avian Diseases, 33, 177-181. https://doi.org/10.2307/1591085
[38]
Richardson and Smith (1981) Resistance of Virulent and Attenuated Strains of Candida albicans to Intracellular Killing by Human and Mouse Phagocytes. The Journal of Infectious Diseases, 144, 557-565. https://doi.org/10.1093/infdis/144.6.557
[39]
Chang, X., Mallard, B.A. and Mowat, D.N. (1996) Effects of Chromium on Health Status, Blood Neutrophil Phagocytosis and in Vitro Lymphocyte Blastogenesis of Dairy Cows. Veterinary Immunology and Immunopathology, 52, 37-52. https://doi.org/10.1016/0165-2427(95)05539-8
[40]
Roth, J.A. (2011) Veterinary Vaccines and Their Importance to Animal Health and Public Health. Procedia in Vaccinology, 5, 127-136. https://doi.org/10.1016/j.provac.2011.10.009
[41]
Cohen, J. and Marshall, E. (2001) Bioterrorism. Vaccines for Biodefense: A System in Distress. Science, 294, 498-501. https://doi.org/10.1126/science.294.5542.498
[42]
Curtiss, R. (2002) Bacterial Infectious Disease Control by Vaccine Development. Journal of Clinical Investigation, 110, 1061-1066. https://doi.org/10.1172/JCI0216941
[43]
Billecocq, A., Vialat, P. and Bouloy, M. (2018) Persistent Infection of Mammalian Cells by Rift Valley Fever Virus. https://www.microbiologyresearch.or
[44]
Wassel, M.S., Aboulsaoud, S., Girgis, S., Hussein, A.Z. and Eman, E.R. (1996) Trials for Elaboration and Evaluation of a Combined Vaccine for IBR (IBR-V), (BVD), (PI-3V), P. multocida and P. haemolytica in Egypt. Assiut Veterinary Medical Journal, 35, 130-143. https://doi.org/10.21608/avmj.1996.183958
[45]
Rajput, Z.I., Hu, S.-H., Xiao, C.-W. and Arijo, A.G. (2007) Adjuvant Effects of Saponins on Animal Immune Responses. Journal of Zhejiang University. Science B, 8, 153-161. https://doi.org/10.1631/jzus.2007.B0153
[46]
Lisa, G.M., et al. (2022) Saponin-Based Adjuvant-Induced Dendritic Cell Cross-Presentation Is Dependent on PERK Activation. Cellular and Molecular Life Sciences, 79, Article No. 231. https://doi.org/10.1007/s00018-022-04253-x
[47]
Yendoa, A.C.A., De Costaa, F., Cibulski, S.P., Teixeira, T.F., Colling, L.C., Mastro-giovanni, M., et al. (2016) A Rabies Vaccine Adjuvanted with Saponins from Leaves of the Soap Tree (Quillaja brasiliensis) Induces Specific Immune Responses and Protects against Lethal Challenge. Vaccine, 34, 2305-2311. https://doi.org/10.1016/j.vaccine.2016.03.070
